Latest LEO Pharma News & Updates
See the latest news and media coverage for LEO Pharma. We track all announcements, press releases, and industry mentions in real time, all in one place.
Medical dermatology pharmaceutical company
leo-pharma.com- Headquarters
- Ballerup, Denmark
- Founded year
- 1908
- Company type
- Private company
- Number of employees
- 1,000–5,500
Latest news about LEO Pharma
Company announcements
-
LEO Pharma acquires Replay.
This acquisition deepens commitment to rare dermatology and expands innovation. It highlights collaboration with DEBRA Research.
-
LEO Pharma acquires Replay
The acquisition adds Replay's HSV gene therapy platform targeting rare skin diseases like DEB to LEO Pharma's pipeline. It combines dermatology expertise with next-generation therapy.
-
LEO Pharma gains NMPA approval for Enstilar in China
The approval expands access to Enstilar foam for 6.5 million plaque psoriasis patients. Launch planned later this year.
-
LEO Pharma calls for a clear course for Denmark's life science sector
CEO Christophe Bourdon and other CEOs urge the incoming government to ensure access to treatments and strengthen competitiveness. They offer collaboration on solutions.
Media coverage
-
Leo Pharma Is Said to Add More Banks to Copenhagen IPO Lineup
Leo Pharma AS has picked more banks to help it prepare for a possible initial public offering in...
-
Leo Pharma buys up for 320 million - bets on golden egg before stock listing
Leo Pharma is now using over 300 million kroner on an acquisition that will become a crucial growth hope in the portfolio of medicines. For Leo Pharma, the course...
-
Delgocitinib Leads to Strong 16-Week Improvement in Chronic Hand Eczema
Regulatory milestones include EMA approval in 2024 and FDA approval in 2025 for chronic hand eczema, addressing limitations of prolonged topical corticosteroid use. Across 3...
-
LEO Pharma expands its psoriasis portfolio in China with NMPA approval of Enstilar®
LEO Pharma expands its psoriasis portfolio in China with NMPA approval of Enstilar® NMPA approval of Enstilar® in China marks a significant milestone for LEO...
Track LEO Pharma and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
LEO Pharma competitors & trending companies
Browse news for competitors to LEO Pharma and other trending companies.
Organon
Sironax
Aperture Therapeutics
Attentive
Klaviyo
Twilio
Insider One
Zeta Global
Iterable
Braze
Optimove
Bluecore
BlueConic
Amperity
Wero
BLIK
EPI
Swish
Affirm
Brite Payments
TCS
Overview Energy
Adfin
Ineffable Intelligence
Mechanize
Hexatronic
Alimak Group
Lindab Group
NYAB
Noon Energy
Nordan AI
Mips
Vexlum
Asker Healthcare Group